NRG1 and schizophrenia: A study by Yang et al. found that positive improvements in attention and reasoning in patients suffering from schizophrenia, after 12 weeks of risperidone treatment, were associated with the rs3924999 and rs35753505 polymorphisms of NRG1 [42].